Stiefel Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STIEFEL, and what generic and branded alternatives to STIEFEL drugs are available?
STIEFEL has five approved drugs.
Summary for Stiefel
US Patents: | 0 |
Tradenames: | 4 |
Ingredients: | 4 |
NDAs: | 5 |
Patent Litigation for Stiefel: | See patent lawsuits for Stiefel |
Drugs and US Patents for Stiefel
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-003 | Aug 6, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-002 | Oct 28, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Stiefel | DUAC | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 050741-001 | Aug 26, 2002 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Stiefel | SCABENE | lindane | LOTION;TOPICAL | 086769-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Stiefel
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Stiefel | DUAC | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 050741-001 | Aug 26, 2002 | 5,466,446 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for STIEFEL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Gel | 1% / 5% | ➤ Subscribe | 2008-12-11 |
Similar Applicant Names
Here is a list of applicants with similar names.